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Intestinal bacteria outnumber our own human cells in conditions of both health and dis-
ease. It has long been recognized that secretory antibody, particularly IgA, is produced
in response to these microbes and hypothesized that this must play an important role in
deﬁning the relationship between a host and its intestinal microbes. However, the exact
role of IgA and the mechanisms by which IgA can act are only beginning to be under-
stood. In this review we attempt to unravel the complex interaction between so-called
“natural,” “primitive” (T-cell-independent), and “classical” IgA responses, the nature of
the intestinal microbiota/intestinal pathogens and the highly ﬂexible dynamic homeostasis
of the mucosal immune system. Such an analysis reveals that low-afﬁnity IgA is sufﬁcient
to protect the host from excess mucosal immune activation induced by harmless com-
mensal microbes. However, afﬁnity-maturation of “classical” IgA is essential to provide
protection from more invasive commensal species such as segmented ﬁlamentous bacte-
ria and from true pathogens such as Salmonella typhimurium.Thus a correlation is revealed
between “sophistication” of the IgA response and aggressiveness of the challenge. A sec-
ond emerging theme is that more-invasive species take advantage of host inﬂammatory
mechanisms to more successfully compete with the resident microbiota. In many cases,
the function of IgAmay be to limit such inﬂammatory responses, either directly by coagulat-
ing or inhibiting virulence of bacteria before they can interact with the host or bymodulating
immune signaling induced by host recognition.Therefore IgA appears to provide an added
layer of robustness in the intestinal ecosystem, promoting “commensal-like” behavior of
its residents.
Keywords: mucosal immunology, IgA, microbiota, mucosal infection, natural antibody, adaptive immunity, innate
immunity
INTRODUCTION
Immunity at our mucosal surfaces at ﬁrst appears to tread a
very ﬁne line between excessive pathological responsiveness to the
abundant commensal microbes, and insufﬁcient responsiveness to
potentially pathogenic microbes. In reality, the composition of the
microbiota varies with circadian rhythm (Caporaso et al., 2011),
eating (Kiss et al., 2011; Li et al., 2011), chemical toxins (Veldhoen
et al., 2008), etc. Further, a broad range of immunodeﬁciencies
(Vaishnava et al., 2008; Slack et al., 2009) are known to be com-
patible with the formation of host–commensal mutualism at least
with a speciﬁc-pathogen-free microbiota. Thus it is revealed that
the host–microbiota relationship is a dynamic homeostasis that is
both remarkably robust andmechanistically ﬂexible. The observed
inﬂammation and induction of high-afﬁnity adaptive immune
responses during pathogenic infection can be seen as a (preferably
temporary) deviation of the bacterial–host relationship sharply
away from its usual homeostatic set-point, with the correspond-
ing decrease in function of the intestine that accompanies any such
deviation.
The study of genetically manipulated mice has revealed many
factors that contribute to the robustness of this homeostasis
[including mucus production (Van der Sluis et al., 2006; Johans-
son et al., 2008), antimicrobial peptide production (Vaishnava
et al., 2008, 2011), innate immunity (Slack et al., 2009)]. This
robustness may also explain how the intestinal immune system is
able to accommodate a wide range of microbes that have evolved
a wide variety of intestinal lifestyles ranging from symbiotic to
opportunistic pathogenic/“pathobiotic” (Chow et al., 2011).
For many years, the role of intestinal IgA in host–commensal,
and host–pathogen, interactions has been actively pursued. The
mild phenotype of IgA-deﬁciency both in mice and in humans
[approx. 1 in 600 Caucasians fail to secrete measurable quantities
of IgA into the intestine without any clear association to clinical
disease (Hammarström et al., 2000)] may be easily explained by
the necessary robustness of the intestinal immune system. Nev-
ertheless, IgA is normally produced at a rate of 5 g/day, making
it the most abundantly produced antibody isotype, and a consid-
erable metabolic burden. This hints toward a strong evolutionary
selective pressure for its maintenance. The purpose of this review
is to discuss recently published progress in our understanding of
the role and mechanisms of action of secretory IgA in mucosal
homeostasis, mucosal vaccination, and responses to infection.
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MICROBIOTA-DRIVEN IgA – IS IT “NATURAL”?
“PRIMITIVE” AND “CLASSICAL” IgA
Before we consider the function of IgA, it is ﬁrst pertinent to dis-
cuss one major aspect of IgA biology: many IgA responses are
considered to be “primitive” (Macpherson et al., 2000), but the
exact meaning of this is easily confused with “natural” and/or
“innate.”
Evidence of secretory antibodies can be seen in the genome of
species as diverse as cartilaginous ﬁsh, amphibians, and mammals.
Intriguingly, teleost ﬁsh, which branched from the mammalian
and cartilaginous ﬁsh lineages during the Triassic period, pro-
duce only variants of IgM with no evidence of intestinal secretion
(Tort et al., 2003). This suggests that mammalian IgA arose later
than the divergence of teleosts and the rest of the Gnathostomata
species, and is therefore considerably less ancient than the adaptive
immune system itself.
Nevertheless, although “classical” adaptive immunity generates
high-afﬁnity antibodies via T-cell driven somatic hypermutation
(Table 1), T-cell-deﬁcient mice can still produce so-called “primi-
tive” IgA (Table 1) of a sufﬁcient afﬁnity/avidity to bind commen-
sal bacterial antigens on a western blot or ELISA. This suggests
that commensal-induced IgA does not absolutely require classical
T-cell help for its generation (Macpherson et al., 2000, 2001). The
term “primitive” here refers to the seemingly simpler induction
mechanism not involving T-cells. It is intriguing to note that the
breadth of epitopes, particularly of carbohydrate epitopes never
produced by mammalian cells, is much broader in bacteria than
in commonly studied viruses such as LCMV (which necessarily
rely upon host protein and carbohydrate synthesis machinery).
This potentially allows for evolutionary selection of antibody V,
D, and J segments capable of forming high-afﬁnity interactions
with common bacterial antigens even in germ-line conforma-
tion. Indeed, (monoclonal) IgA isolated from monocolonized
mice commonly displays no evidence of somatic hypermutation
(Bos et al., 1996; Hapfelmeier et al., 2010; Wei et al., 2011; Lind-
ner et al., 2012) but nevertheless can be of sufﬁcient afﬁnity to
bind to the bacterial surface of the colonizing species in a ﬂow
cytometry stain (where the typical afﬁnity minimum cut-off is
considered to be around 109 L/mol (Macey, 2007) as opposed to
much lower afﬁnity cut-offs that can be detected by Western blot
or “dirty-plate” ELISA).
The above observations all support the idea that IgA can be
produced in a “primitive” fashion, independently from T-cell-
mediated immunity. However, it should be noted that bacterial
binding by IgA from T-cell-deﬁcient mice is observed when total
IgA concentrations are normalized between wild-type and T-cell-
deﬁcient mice, but total intestinal IgA levels are lower in T-cell-
deﬁcient mice than in wild-type mice, depending on the micro-
biota (Macpherson et al., 2000). Further, when T-cell-deﬁcient
or CD4 T-cell-depleted mice are challenged intragastrically with
either a commensal or a pathogen, we cannot detect IgA of sufﬁ-
cient afﬁnity to be measured by ﬂow cytometry staining of the
bacterial surface, even when total IgA concentrations are nor-
malized (Slack et al., 2009; Slack and Hapfelmeier, unpublished
observations). As well as T-cells, organized lymphoid structures in
the intestine are required for a substantial proportion of IgA+
plasma cell generation as production of these cells is severely
impaired in mice lacking RORγt which fail to develop any orga-
nized lymphoid structures in the intestine (Eberl and Littman,
2004), lymphotoxin-alpha deﬁcient mice which lack all organized
lymphoid structures in the intestine (Kang et al., 2002; Newberry
et al., 2002), and RORγt-deﬁcient mice reconstituted with bone
marrow from lymphotoxin-alpha deﬁcient mice which fail to gen-
erate follicular dendritic cells in the Peyer’s patches (PP; Tsuji et al.,
2008). Further, germinal centers are always histologically observed
in the mucosa-associated lymphoid tissues of SPF or recently bac-
terially colonized animals (Talham et al., 1999; Hapfelmeier et al.,
2010). Therefore, although“primitive”bacterially induced IgA can
be observed in the absence of “classical” T-cell-dependent anti-
body responses, the generation of abundant and high-afﬁnity IgA
still appears to require CD4 T-cell help and organized lymphoid
structures.
“NATURAL” AND “INNATE” IgA
How these responses relate to what are deﬁned as “natural” and
“innate”antibody responses is also intriguing.Classically,“natural”
responses are deﬁned as pre-existing antibody responses that an
animal produces in the absence of microbial or antigenic stim-
ulation. Until recently, all antibodies in the serum and intestine
of an unvaccinated uninfected SPF animal would be considered
“natural.” However, at least 90% of the IgA in the intestine is
induced by the microbiota (to be further discussed below, see
section The Role of of IgA in Host–Commensal Mutualism), sug-
gesting this term can only be classically applied to the antibody
responses found in germ-free mice (Table 1). Germ-free animals
produce reduced but still signiﬁcant amounts of intestinal IgA.
Recent next-generation sequencing of the IgA repertoire indicates
that this “natural” repertoire contains a similar distribution of low
frequency and high frequency plasma cell clones to that in SPF
mice (Lindner et al., 2012).However, intestinal IgA fromgerm-free
mice does not contain sufﬁcient levels of bacterial-antigen-speciﬁc
clones to bind bacterial antigens on western blots, even when
total IgA concentrations are normalized (Macpherson et al., 2000,
2001).
In the ﬁelds of virology, antibody afﬁnities of greater than
108L/mol are required to neutralize infection with extensively
characterized viruses such as VSV (Bachmann et al., 1997). Such
antibody responses are only induced after extensive somatic hyper-
mutation during germinal center reactions, and in this situation,
the distinction between natural antibody responses and induced
antibody responses is simple to make. For anti-bacterial antibod-
ies, it is almost impossible to deﬁne a bacterial equivalent of “neu-
tralizing” antibody unless the response is bacterial toxin-speciﬁc,
adding considerably to the complexity of discussion.
Thus, both “primitive” T-independent, and “classical” adap-
tive T-dependent IgA responses appear to operate in parallel in
the intestine to provide both extremely rapid, and slower but
higher-afﬁnity responses to bacteria, as appropriate. How “nat-
ural” the IgA response is in both situations remains to be fully
explored, but next-generation-sequencing-based approaches to
the IgA repertoire are beginning to provide clear answers to this:
there is evidence for the microbiota-induced rapid expansion of
a near-germ-line “natural” IgA repertoire (pre-existent in new-
borns and germ-free animals) combined with the subsequent
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Table 1 | Key features of “natural,” “primitive,” and “classical” intestinal IgA.
IgA type Induced by Microbial
affinity
T-cell-
dependent
Somatic hypermutation Delay of onset Selected reference
Natural ? Negligible No None 0 (pre-exists) Macpherson et al. (2001),
Lindner et al. (2012), Harris
et al. (2006)
Primitive Microbes Low–moderate No None Fast (<14 days) Macpherson et al. (2000,
2001), Lindner et al. (2012),
Bos et al. (1996)
Classical Microbes (predominantly
pathobionts, pathogens)
High Yes High (time/age-dependent) Slow (>14 days) Wei et al. (2011), Lindner et al.
(2012), Bos et al. (1996)
gradual diversiﬁcation of this repertoire by T-dependent somatic
hypermutation in the murine intestine (Wei et al., 2011; Lindner
et al., 2012). The relative contributions of the different types of
responses to the various functions of IgA are now starting to be
unraveled and will be discussed below.
FUNCTIONS OF INTESTINAL IgA
The commensal microbiota of a free-living mammal contains a
range of species from those which barely interact with the host, via
organisms that form truly mutualistic relationships (Bacteroides
thetaiotaomicron,Lactococcus lactis) through towell knownoppor-
tunistic pathogens (Staphylococcus aureus, Clostridium difﬁcile)
and “pathobionts” [e.g., “segmented ﬁlamentous bacteria” (SFB);
Chow et al., 2011]. It should be noted that all such terms are
an attempt to draw lines onto the continuous spectrum of bac-
terial behaviors that depend not only on the bacterial species,
but also on the host. Indeed bacteria that have been deﬁned as
true commensals or “pathobionts” in wild-type mice can begin
to display behavior of true opportunistic pathogens in immuno-
compromised mouse strains (Fagarasan et al., 2002; Elinav et al.,
2011; Wei et al., 2011; Henao-Mejia et al., 2012) further indicat-
ing the ﬂexibility of these deﬁnitions. A useful distinction is thus
that commensalism represents a state of homeostasis that can be
maintained long-term, whereas pathogenic infection represents a
major deviation from this homeostasis. The function of IgA in
both of these situations will be discussed below.
THE ROLE OF IgA IN HOST–COMMENSAL MUTUALISM
It is well established that themajority (approx.>90%) of intestinal
IgAproduction ismicrobiota-driven, since germ-free animals con-
tain around 10-fold reduced numbers of mucosal IgA-producing
cells (Crabbé et al., 1970; Moreau et al., 1978). This state is read-
ily reversed by the re-association of such animals with a normal
microbiota (Crabbé et al., 1970; Moreau et al., 1978). In line with
this it was shown that most intestinal bacterial cells are IgA-coated
in situ (van der Waaij et al., 1996), but it has also been noted
that not all IgA that is induced by a speciﬁc commensal microbe
has detectable reactivity to the inducing microbe (Bry et al., 1996;
Talham et al., 1999; see also Stoel et al., 2005).
Compensatory immune reactions reveal IgA-mediated modulation of
immune function
The study of severely innate immunedeﬁcientmice has shown that
both innate and adaptive immunity are critically important for
intestinal containment also of commensal bacteria (even the com-
pletely avirulent laboratory model organism E. coli K-12). Indeed,
considerable functional complementarity of innate and adaptive
immunity can compensate for partial immune deﬁciency (Slack
et al., 2009). This ﬂexibility almost certainly also underlies the
lack of overt pathology in IgA−/− or even completely antibody-
deﬁcient animals (Shulzhenko et al., 2011). It also suggests that
the functionality of IgA in host–commensal interaction is best
measured indirectly by measuring upregulation of other, compen-
satory commensal-induced mucosal immune mechanisms. This
has been successfully observed in a number of recent publications,
which can be roughly divided into those showing an effect of non-
speciﬁc IgA, those showing an effect of total IgA and those showing
an effect of high-afﬁnity IgA.
The work published by Petersen et al. (Peterson et al., 2007),
demonstrates that a monoclonal antibody with high-afﬁnity for
the surface of Bacteroides thetaiotaomicron can speciﬁcally reduce
intestinal innate immune activation in a B. thetaiotaomicron-
monocolonized hybridoma back-pack RAG1-deﬁcient (therefore
T and B cell-deﬁcient) mouse model. Increased innate immune
activation is also observed in the epithelium of completely
antibody-deﬁcient mice (Shulzhenko et al., 2011). Previous stud-
ies have also reported spontaneous pathology and small intestinal
bacterial overgrowth, predominantly of the “pathobiont” SFB, in
AID-deﬁcient mice,which have a defect in somatic hypermutation
(Fagarasan et al., 2002; Suzuki et al., 2004; Wei et al., 2011), sug-
gesting that afﬁnity-matured IgA responses are necessary for the
control of this species. In contrast to these studies on high-afﬁnity
antibodies, quasi-monoclonal IgA from Qm mice, and also the
“natural” IgA from germ-free mice, was shown to be sufﬁcient to
prevent premature primingof antibody responses against the com-
mensalmicrobiota in neonatalmice,despite presumably negligible
afﬁnity of this IgA for the intestinalmicrobiota (Harris et al., 2006).
Elson and co-workers report another indirect IgA effect in host–
commensal mutualism by showing that IgA-deﬁciency leads to
increased commensal-driven generation of intestinal FoxP3+ reg-
ulatory T-cells (Cong et al., 2009), although no distinction could
be made between low-afﬁnity and high-afﬁnity IgA responses in
this system.
Taken in parallel with the absence of intestinal inﬂammation
in IgA or antibody-deﬁcient mice in many animal facilities, this
suggests that requirements of the IgA system for maintaining
homeostasis are highly dependent on the nature of the intestinal
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microbiota. In the majority of SPF facilities, compensation by
other immune mechanisms appears to prevent the appearance of
clinically overt disease. Whilst afﬁnity-matured antibodies appear
to be necessary to protect against immune activation caused by
bacteria like SFB, non-speciﬁc IgA such as in the QM mice, is
sufﬁcient to prevent early immune activation by a less invasive
microbiota (Figure 1).
Mechanisms of IgA-mediated immune modulation
The mechanism by which IgA can minimize induction of innate or
adaptive immunity in the intestine remains to be deﬁnitely proven.
This may be achieved by decreasing bacterial penetration of the
intestinal epithelial barrier andminimizing access of bacterial anti-
gen to gut associated lymphoid tissues (GALT), or by alteration of
immune signaling induced by recognition of IgA-coated bacteria
in the epithelium and lamina propria.
The ﬁrst of these mechanisms could be called “innate immune
exclusion”, in analogy of the classical term of “immune exclu-
sion” (i.e., the effect of IgA in downregulating its own induction
by excluding the cognate antigen from accessing IgA inductive
sites [Stokes et al., 1975]). A prominent example of this is the
monocolonization of germ-free animals with a strongly IgA-
inducing commensal bacterium like Morganella morganii. Despite
the persistent nature of bacterial intestinal colonization, this leads
to a contained IgA response with only transient germinal center
reactions (Shroff et al., 1995).
Recent progress in this ﬁeld has led to a more detailed consid-
eration of intestinal mucus in such an exclusion mechanism. The
viscous mucous layer covering the intestinal epithelium physically
impedes bacterial contact with the epithelium and concentrates
secreted antimicrobials that kill mucus-invading bacteria, with-
out affecting the commensal habitat as a whole. If the viscous
mucus layer is missing, the micro-compartmentalized nature of
the mucosal barrier literally collapses. This can precipitate exces-
sive defense reactions toward commensal bacteria and chronic
inﬂammatory disease, as can be observed in Muc2-deﬁcient mice
(Van der Sluis et al., 2006; Johansson et al., 2008). It has recently
been demonstrated that the antimicrobial peptide RegIIIγ is
concentrated in the mucus layer and deﬁciency for this pep-
tide results in heavy bacterial colonization of the mucus layer
(Vaishnava et al., 2011). Histologically it is also clear that IgA
is concentrated in the intestinal mucus, and similar experiments
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FIGURE 1 | Schematic of the composite nature of the mucosal IgA
system, consisting of “natural” (microbiota-independent), “primitive”
(microbobially induced,T-cell independent), and “classical”
(microbe/pathogen-induced, helperT-cell-dependent) IgA responses.
Whether there is a speciﬁc immunogen inducing “natural” IgA is unknown.
“Natural” IgA can be sufﬁcient for controlling benign commensal bacteria.
Commensal microbes induce “primitive”T-cell independent IgA with is
sufﬁcient for the management of commensal bacteria (Green), mainly by
exclusion from the mucus layer and the resulting “buffering” of mucosal
responses. The more invasive pathobionts (orange) and infection with
pathogenic microbes (red) further induce “classical” T-cell-dependent IgA of
high-afﬁnity that is important for the control of these types of microorganisms
via efﬁcient mucosal exclusion and neutralization. SHM, somatic
hypermutation.
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examining mucus colonization in IgA-deﬁcient and antibody-
deﬁcient animals would reveal whether IgA contributes to the
sterility of the intestinal mucus.
A second possible mechanism is that recognition of IgA-coated
bacteria induces altered signaling when compared to recognition
of bacteria alone. Many different proteins have been suggested to
bind IgA, in addition to the PolyIg receptor that mediates its trans-
port across epithelia. These include the Fcα/μR (Shibuya et al.,
2000), CD89 (reviewed in (Bakema and van Egmond, 2011)),
asialoglycoprotein receptors (Stockert et al., 1982), transferrin
receptors (CD71; Moura et al., 2001), and secretory component
receptors (Lamkhioued et al., 1995). In humans the IgA recep-
tor CD89 is expressed on myeloid cells (although absent from
intestinal macrophages) and can signal in either an activatory
or inhibitory manner depending on the degree of cross-linking
(Reviewed in (Bakema and van Egmond, 2011)). Although mice
lack a direct homolog of CD89, transgenic mice expressing human
CD89 on myeloid cells and passively transferred with human
IgA speciﬁc for mycobacterium tuberculosis were protected from
infection (Balu et al., 2011). IgA can be shown to bind to the sur-
face of murinemacrophages, suggesting that a functional homolog
of CD89 exists, but as yet the responsible receptor complex has not
been identiﬁed (Reljic, 2006). Until further characterization of IgA
receptors in the common murine models has been achieved, sig-
naling induced by IgA in different contexts will remain hard to
deﬁne.
A third proposed mechanism of action of IgA appears para-
doxical to the ﬁrst. It has been observed that IgA also plays a
role in increasing the translocation of bacteria across PP follicle
associated epithelia, where IgA-coated bacteria bind to the lumi-
nal side and are transcytosed into the PP (Kadaoui and Corthésy,
2007; reviewed in Corthésy, 2007, 2009). However, it is still not
fully understood whether the IgA-coated antigen then feeds into a
positive or negative feedback loop of antigen presentation for the
regulation of bacterial-speciﬁc antibody responses. It is important
to keep this bacterial-uptake mechanism in mind, as a common
measure of mucosal containment defects is to quantify the load of
live bacteria present in the PPs and MLNs. An absence of phe-
notype in IgA-deﬁcient mice by this method may represent a
composite of decreased active transport into the PP and increased
passive translocation, masking the effect. This also suggests that
the concept of IgA-mediated exclusion of bacteria from the lam-
ina propria is over-simpliﬁed and the immune consequences of
recognition of IgA-coated bacteria need to be fully investigated.
An entirely different mechanism by which IgA may function is
a possible direct effect of IgA on commensal bacterial coloniza-
tion of the intestine (such as by inﬂuencing growth rate, survival,
bacterial responses, etc.). Despite enormous technical innovation
and experimental creativity, the attempts to demonstrate effects
of immune functions on microbiota composition have been a
challenge and so far have only found subtle effects of mucosal
immunity on the commensal bacterial ﬁtness (Peterson et al., 2007;
Goodman et al., 2009). Supporting functional data for the impact
of bacteria-binding IgA on commensal bacterial ﬁtness come from
the Peterson at al. study (Peterson et al., 2007) where it could be
demonstrated that phase variation of surface polysaccharide that
leads to escape from IgA recognition confers a selective advantage
for intestinal colonization. Interestingly, it is known that inﬂam-
matory responses, such as increased antimicrobial peptide pro-
duction and upregulation of siderophore-sequestering proteins,
negatively impact on commensal bacteria. Therefore beneﬁcial
effects of IgA on commensal colonization may also be indirect
via modulation of the activation state of the mucosal immune
system.
In conclusion, the immune set-points and anatomy of the
mucosal barrier together with IgA may function primarily in
robustly “protecting commensals from themselves,” to avoid
unnecessary inﬂammatory reactions where the collateral damage
would always outweigh the beneﬁts and likely lead to a chronic
state of exaggerated inﬂammation as in inﬂammatory bowel dis-
eases. IgA is therefore a typical example of a mucosal immune
specialization with the potential to actively exclude bacteria from
host tissues without any concomitant induction of acute inﬂam-
mation, thus broadening the window of immune system and
physical barrier function compatible with stable host–microbiota
homeostasis.
FUNCTIONS OF IgA IN BACTERIAL PATHOGEN DEFENSE
In considering the literature on the role of IgA in pathogen defense,
it is also crucial to make the distinction between low-afﬁnity pre-
existing IgA responses found in animals never previously exposed
to the pathogen, and high-afﬁnity IgA responses formed during
vaccination or by previous exposure to the pathogen.
Can “Natural” IgA protect against pathogens?
In contrast to our knowledge on the role of low-afﬁnity IgA
responses in host–commensal mutualism, only limited data sup-
ports a role of low-afﬁnity antibodies in protecting from acute
infection with bona ﬁde obligate pathogens. Indeed PolyIg recep-
tor (pIgR)-deﬁcient mice, which fail to transport any polymeric
immunoglobulin into the intestinal lumen, are equally as sus-
ceptible as wild-type mice in the typhoid model of Salmo-
nella typhimurium infection (Uren et al., 2005), although pIgR-
deﬁcient mice have a reduced colonization resistance toward S.
typhimurium (Wijburg et al., 2006). However, this may in part be
a consequence of the mild non-speciﬁc protein losing enteropa-
thy phenotype of this mouse strain in some hygiene conditions
(Johansen et al., 1999). Our own data in the streptomycin-
pretreatment model of non-typhoidal salmonellosis further con-
ﬁrm these observations (E. Slack and W.-D. Hardt, unpublished
data). Similarly, naive IgA-knock-out mice show comparable sus-
ceptibility to Inﬂuenza infection, to naïve wild-type controls
(Mbawuike et al., 1999). Importantly, given the recent progress in
our understanding of the role of the microbiota in disease (Stecher
and Hardt, 2011), it would be valuable for the ﬁeld to revisit these
observations in gnotobiotic settings. Further, the presence of pos-
sible masking of natural IgA effects by compensatory production
of other isotypes, of increased innate immunity and increased
innate lymphoid cell and T-cell function requires full exploration.
However, although antibody-mediated-compensation for innate
immunodeﬁciency in MyD88-deﬁcient mice is sufﬁcient to pro-
tect these animals from some commensal bacterial species (Slack
et al., 2009), this was shown to be insufﬁcient to protect from
Salmonella infection (Ko et al., 2009).
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High-afﬁnity “classical” IgA induced by pathogens
Induced IgA responses with measurable afﬁnity for particular
pathogens have been extensively investigated in the context of
mucosal vaccination. Early experiments with cholera toxin vacci-
nation demonstrated strong induction of IgA after gastric admin-
istration of the toxin (Svennerholm et al., 1978; Fuhrman and
Cebra, 1981). Svennerholm et al. further showed a strong correla-
tion between the titer of IgA against cholera toxin and protection
from murine cholera infection. Later, “back-pack” IgA-producing
hybridoma experiments and adoptive transfer of monoclonal
dimeric IgA revealed that Vibrio cholerae LPS-speciﬁc IgA was
protective against murine cholera whereas anti-toxin IgA alone
provided very limited protection (Winner et al., 1991; Apter et al.,
1993), although the relative afﬁnities of the IgA clones employed
were not assessed. It could also be demonstrated that adoptive
transfer with a monoclonal dimeric IgA speciﬁc for the outer
membrane of Helicobacter felis could protect germ-free mice from
Helicobacter infection (Czinn et al., 1993). Endt et al. (2010)
recently elucidated that high-afﬁnity surface (predominantly LPS
O-antigen)-binding IgA protects from colitis upon re-infection
with S. typhimurium in the non-typhoidal salmonellosis model.
This appears to be mediated by antibody-mediated bacterial coag-
ulation and“luminal trapping,”hindering innate immune recogni-
tion and bacterial delivery of proinﬂammatory effector molecules.
It was recently found that pathogen-binding IgA can also protect
from pathogens by direct modulation of bacterial motility (Forbes
et al., 2008) or virulence organelles, such as type III secretion sys-
tems. For example, a monoclonal Shigella ﬂexneri LPS-O-antigen
speciﬁc IgA antibody when bound to the bacterial surface speciﬁ-
cally inhibits the S. ﬂexneri type III secretion system that is required
for epithelial invasion and induction of pathology (Forbes et al.,
2011). In analogy to the virus-neutralizing antibodies that directly
protect from virus infection, these antibodies could be termed
“bacteria-neutralizing.” Taken together, these studies indicate that
high-afﬁnity IgA responses can provide protection against a num-
ber of gastrointestinal pathogens in the stomach and intestines.
Mechanisms of IgA “immune diplomacy” – dampening inﬂammation
wherever it can be avoided
Although counterintuitive at ﬁrst, an important protective mecha-
nism of high-afﬁnity secretory IgA appears to be also the dampen-
ing of bactericidal immune responses provoked by certainmucosal
pathogens, for the beneﬁt of the commensal microbiota and for
intestinal homeostasis. Seminal work by Stecher et al. and oth-
ers (Lupp et al., 2007; Stecher et al., 2007; Ackermann et al.,
2008; Brown et al., 2008) introduced the concept that mucosal
pathogens such as Salmonella and Citrobacter cause pathology
not with the primary goal of colonizing extra-intestinal sites
(which may eventually kill the host), but rather to modify the
intestinal microenvironment to improve their competitive edge.
Commensal species are continuously selected by conditions found
within the non-inﬂamed intestine; i.e., competition for space and
resources and resistance to constitutive antimicrobial activity. The
majority of mechanisms required to resist full-blown host inﬂam-
matory immune responses are energy-demanding and therefore
often absent from commensal species. On the other hand, obligate
pathogens require such resistance mechanisms to survive and
propagate. Although it at ﬁrst seems counterintuitive, for many
intestinal bacterial pathogens induction of inﬂammation actually
provides them with a signiﬁcant advantage over the commen-
sal microbiota, that are more susceptible to induced immunity.
The role of intestinal IgA may therefore be two-fold: Firstly
directly inhibiting adhesion, effacement and invasion by intesti-
nal pathogens and secondly, limiting the induction of inﬂam-
mation by such pathogens. This hypothesis is nicely supported
by the observation that LPS O-antigen-speciﬁc IgA can prevent
Salmonella from interacting with the intestinal epithelium, thus
preventing induction of inﬂammation and allowing the commen-
sal microbiota to re-grow (Endt et al., 2010). The speciﬁc role of
anti-bacterial IgA in dampening the bacterial elicitation of inﬂam-
matory responses has also been worked out for Shigella [in a rabbit
ligated ileal loop infection model (Boullier et al., 2009)] coming
to similar conclusions.
TNFα/iNOS-producing IgA plasma cells – more than just IgA
producers
A recent ﬁnding now indicates that IgA-producing cells in the
intestine may have crucial immune functions beyond IgA pro-
duction. Local intestinal production of nitric oxide catalyzed by
the inducible nitric oxide synthase (iNOS) is important for class
switch recombination to IgA and generation of small intestinal
IgA plasma cells (Tezuka et al., 2007). A recent study identiﬁed
the IgA plasma cells themselves as a dominant iNOS and TNFα-
producing cell population of the intestinal lamina propria, and
B-lineage-speciﬁcTNFα/iNOSdeﬁciency led to a an intestinal IgA-
deﬁciency equivalent to a full TNFα/iNOS double knockout (Fritz
et al., 2012). Intriguingly, the generation of these TNFα/iNOS-
producing IgA plasma cells required microbial exposure, since
the baseline lamina propria IgA plasma cells of germ-free ani-
mals consisted only of TNFα/iNOS-negative cells (Fritz et al.,
2012). Colonization and infection experiments using mice with
a B cell speciﬁc TNFα/iNOS deﬁciency further suggested that
B-lineage-derived TNFα/iNOS contributed to the control of Cit-
robacter rodentium infection and intestinal colonization with the
pathobiont SFB (Fritz et al., 2012). These observations document a
novel immune regulatory function of IgA plasma cells and suggest
that intestinal microbes induce plasma cells with a more“myeloid”
cell-like phenotype.
The challenge of inducing protective IgA by oral vaccination
A major challenge in mucosal immunology currently is the devel-
opment of vaccines that protect against mucosal infections such
as typhoidal and non-typhoidal salmonellosis, cholera, shigellosis,
enterotoxigenic E. coli, and tuberculosis. Currently many vaccines
tested against these organisms show low efﬁcacy when compared
to vaccination against viruses (measles, inﬂuenza, rubella). In part,
this reﬂects the complexity of the pathogens, although novel vac-
cines against papilloma viruses andVaricella zoster combat organ-
isms approaching bacterial levels of complexity (recently reviewed
in Stanley, 2008; Abendroth et al., 2010). Intracellular bacterial
pathogens appear to be particularly challenging for the immune
system,often residing within macrophages or dendritic cells which
they modify to best evade immune detection (Bedoui et al., 2010).
However, a vaccine that induces a long-lasting high-afﬁnity IgA
response can potentially inhibit the initial infection step before
bacteria become resident intracellular pathogens. This poses two
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challenges for vaccine developers: Firstly, to induce IgA that has a
sufﬁciently high-afﬁnity for a sufﬁcient number of relevant strains.
Secondly, to produce a long-lasting IgA response safely.
Recent experiments using reversible colonization of germ-
free mice indicate that both of these aims are harder to achieve
in the mucosal system than in systemic IgG-based vaccination
(Hapfelmeier et al., 2010). Firstly, the mucosal immune system
is rather insensitive to bacteria. Whereas as few as 103 bacteria
given systemically can induce a robust IgG response, over 109 live
bacteria need to be delivered orally in order to see a measurable
IgA response in the intestine (Hapfelmeier et al., 2010). There-
fore any oral vaccination needs to introduce very high numbers
of the vaccine strain into the system, either by using a live strain
that can colonize to over this density, or by giving extremely high
numbers of non-replicating bacteria. Alternatively, methods need
to be employed that deliver sufﬁcient quantities of antigen across
the mucosal epithelium, or deliver strong enough adjuvanticity
that these numbers can be reduced. Killed bacteria seem to be
at least 100-fold less effective at inducing IgA responses than live
bacteria, presumably due to their inactivity and the digestion of
dead bacteria during transit through the stomach and intestine
(Macpherson and Uhr, 2004; Hapfelmeier et al., 2010). To make
matters worse, there is no clear prime-boost effect of intestinal
immunization. Rather with each oral dose of bacteria there is a
step-wise increase in speciﬁc IgA production that is independent
of the interval between doses.A further challenge is that in the nor-
mally colonized intestine, the rate of attrition of the IgA repertoire
is extremely high (Hapfelmeier et al., 2010). Thus it seems that
any successful IgA-inducing vaccine must contain high numbers
of bacteria, in a format that survives passage through the stomach,
and which provides persistent antigen at a high enough concentra-
tion to avoid attrition of the response. Intriguingly, older works on
the immune response to cholera toxin in the intestine demonstrate
robust prime-boost effects of the IgA response and the presence
of memory B cells up to 16 weeks post vaccination, suggesting
that the nature of the antigen or the adjuvant may be critical in
determining longevity of the IgA response (Pierce, 1978).
Remarkably, it could be demonstrated that intestinal infection
with virulent Salmonella produces more and higher-afﬁnity IgA
than an equally densely colonizing avirulent Salmonella mutant,
and only the IgA induced by virulent bacteria conferred robust
protection from colitis upon re-challenge (Martinoli et al., 2007;
Endt et al., 2010). More needs to be learned about the underly-
ing qualitative and quantitative differences between pathogen and
non-pathogen-induced mucosal immunity to understand this dif-
ference. Presumably, like pathogenic and commensal bacteria, also
virulent and avirulent variants of a pathogen necessitate different
degrees and kinds of immune protection. This is clearly relevant
for the design of mucosal vaccines intended to be protective against
mucosal infections: it is absolutely possible that the optimization
of completely attenuated bacterial strains as live vaccines turns out
to be counterproductive. Such a strategy could lead to agents that
potently induce anti-commensal immunity but not the intended
anti-pathogen immune protection.
IgA-independent protective mucosal immunity
Importantly, whilst IgA can be sufﬁcient for protection from
pathogen infection, it can be demonstrated that immunity
induced by exposure of mice to a live mucosal vaccine or
pathogen is highly redundant and in many cases IgA is dis-
pensable. This has been shown both for Inﬂuenza virus infec-
tion (Mbawuike et al., 1999), and for typhoidal salmonellosis
(Uren et al., 2005). In the non-typhoidal model of salmonel-
losis, Endt et al. (2010) demonstrated robust protection from
colitis by speciﬁc secretory IgA but an absence of steriliz-
ing immunity – indeed clearance of Salmonella from the gut
lumen critically required re-growth of the microbiota, rather
than active immune mechanisms. It has further been observed
in humans that there is no correlation between any anti-
typhoid antibody titer measured in serum or saliva and rate of
recovery from typhoid (Dham and Thompson, 1982). Further,
speciﬁcally induced CD4 effector T-cells can confer antibody-
independent protection from mucosal infection. This was shown
in an intranasal Klebsiella pneumoniae infection model, where
Th17 cells conferred cross-protection between multiple serotypes
of the same pathogen, independent of antibodies (Chen et al.,
2011).
CONCLUSION
The intestinal IgA system acts at the interface between body and
one the densest bacterial consortia known. The challenge of bac-
terial containment and discrimination between non-pathogens
and pathogens has shaped the evolution of an intestinal immune
system that robustly maintains intestinal health due to highly
redundant and functionally ﬂexible barrier functions. The current
literature suggests that IgA adds robustness to host–microbiota
homeostasis in the face of this ﬂexibility, by acting as an immuno-
logical “buffer”: i.e., that combines protection from invasion by
pathogenic microbes with suppression of excessive inﬂammation
induced by non-pathogenic commensal microbes. The afﬁnity
of microbe-IgA interaction required to achieve this buffering
appears to be highly tailored to the invasiveness of the microbial
species in question. How exactly IgA functions in each situation
remains only patchily understood with mechanisms proposed
that directly affect the microorganism or that modulate host
immune signaling. Inducing long-lived, effective mucosal vacci-
nation will require an in-depth understanding of the interaction
of different speciﬁcities and afﬁnities of IgA with the pathogen in
question, as well as the effects of pre-existing IgA and continu-
ous repertoire re-shaping. We propose that great advances in this
ﬁeld will come from a new approach, made possible by modern
technologies, aiming to examine the functioning of IgA within
the mucosal ecosystem as a whole, simultaneously assessing the
effects on microbiota structure and mucosal activation, and sub-
sequently dissecting the crucial relationship between these two
entities.
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